 <h1>Univasc Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>moexipril</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about moexipril. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Univasc.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to moexipril: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Discontinue moexipril hydrochloride as soon as possible once pregnancy is detected since drugs that act directly on the renin-angiotensin system can case injury and death to the developing fetus.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, moexipril (the active ingredient contained in Univasc) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking moexipril:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>chills</li>
<li>confusion</li>
<li>cough</li>
<li>diarrhea</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>fever</li>
<li>headache</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>nausea</li>
<li>runny nose</li>
<li>shivering</li>
<li>sore throat</li>
<li>sweating</li>
<li>trouble sleeping</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of moexipril may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Dry cough</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>congestion</li>
<li>difficulty moving</li>
<li>dizziness</li>
<li>feeling of warmth</li>
<li>hoarseness</li>
<li>muscle cramping</li>
<li>muscle stiffness</li>
<li>rash</li>
<li>redness of the face, neck, arms, and upper chest</li>
<li>swollen joints</li>
<li>tender, swollen glands in the neck</li>
<li>trouble swallowing</li>
<li>voice changes</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to moexipril: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse effects considered to be related to use of this drug were headache, cough, dizziness, fatigue, flushing, and rash.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, flu syndrome, pain, peripheral edema, chest pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Fever</p>
<p><b>Rare</b> (less than 0.1%): Malaise<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, pharyngitis, upper respiratory tract infection, rhinitis, sinusitis</p>
<p><b>Rare</b> (less than 0.1%): Bronchospasm, dyspnea</p>
<p><b>Frequency not reported</b>: Eosinophilic pneumonitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, constipation, vomiting</p>
<p><b>Rare</b> (0.01% to 0.1%): Dry mouth</p>
<p><b>Very rare</b> (less than 0.01%): Pancreatitis</p>
<p><b>Frequency not reported</b>: Intestinal angioedema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Cerebrovascular accident, transient ischemic attack, syncope</p>
<p><b>Rare</b> (less than 0.1%): Numbness, paresthesia, balance disturbance, drowsiness, tingling sensations, alteration or transient loss of taste, tinnitus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Serum creatinine increased, BUN increased</p>
<p><b>Rare</b> (less than 0.1%): Acute renal failure, renal insufficiency<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Stevens-Johnson syndrome, toxic epidermal necrolysis, pruritus, urticaria, erythema multiforme, psoriasis-like efflorescence, pemphigus, alopecia</p>
<p><b>Rare</b> (less than 0.1%): Angioedema</p>
<p><b>Frequency not reported</b>: Sweating, photosensitivity<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, angina pectoris, rhythm disorder, tachycardia, palpitation, hypotension</p>
<p><b>Frequency not reported</b>: Symptomatic hypotension, postural hypotension<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary frequency</p>
<p><b>Rare</b> (less than 0.1%): Impotence</p>
<p><b>Frequency not reported</b>: Oliguria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Appetite loss, uric acid elevated</p>
<p><b>Rare</b> (less than 0.1%): Hyperkalemia</p>
<p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Anemia, neutropenia, eosinophilia, thrombocytopenia</p>
<p><b>Very rare</b> (less than 0.01%): Pancytopenia, agranulocytosis, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, hemoglobin decreased, hematocrit decreased, platelets decreased, white cell count decreased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Confusion, depression, sleep disturbances</p>
<p><b>Frequency not reported</b>: Nervousness, mood changes, anxiety<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Vision blurred<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very rare</b> (less than 0.01%): Hepatitis, liver enzymes elevated, serum bilirubin elevated<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Univasc (moexipril)." Schwarz Pharma, Mequon, WI. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Univasc (moexipril)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: Angiotensin Converting Enzyme Inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Univasc &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Diabetic Kidney Disease</li>
<li>Heart Attack</li>
<li>Heart Failure</li>
<li>High Blood Pressure</li>
<li>Left Ventricular Dysfunction</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to moexipril: oral tablet</i></p><h3>General</h3><p>The most commonly reported adverse effects considered to be related to use of this drug were headache, cough, dizziness, fatigue, flushing, and rash.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, flu syndrome, pain, peripheral edema, chest pain</p><p><b>Uncommon</b> (0.1% to 1%): Fever</p><p><b>Rare</b> (less than 0.1%): Malaise<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, pharyngitis, upper respiratory tract infection, rhinitis, sinusitis</p><p><b>Rare</b> (less than 0.1%): Bronchospasm, dyspnea</p><p><b>Frequency not reported</b>: Eosinophilic pneumonitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, nausea</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, constipation, vomiting</p><p><b>Rare</b> (0.01% to 0.1%): Dry mouth</p><p><b>Very rare</b> (less than 0.01%): Pancreatitis</p><p><b>Frequency not reported</b>: Intestinal angioedema<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Cerebrovascular accident, transient ischemic attack, syncope</p><p><b>Rare</b> (less than 0.1%): Numbness, paresthesia, balance disturbance, drowsiness, tingling sensations, alteration or transient loss of taste, tinnitus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Serum creatinine increased, BUN increased</p><p><b>Rare</b> (less than 0.1%): Acute renal failure, renal insufficiency<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Uncommon</b> (0.1% to 1%): Stevens-Johnson syndrome, toxic epidermal necrolysis, pruritus, urticaria, erythema multiforme, psoriasis-like efflorescence, pemphigus, alopecia</p><p><b>Rare</b> (less than 0.1%): Angioedema</p><p><b>Frequency not reported</b>: Sweating, photosensitivity<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Flushing</p><p><b>Uncommon</b> (0.1% to 1%): Myocardial infarction, angina pectoris, rhythm disorder, tachycardia, palpitation, hypotension</p><p><b>Frequency not reported</b>: Symptomatic hypotension, postural hypotension<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary frequency</p><p><b>Rare</b> (less than 0.1%): Impotence</p><p><b>Frequency not reported</b>: Oliguria<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Appetite loss, uric acid elevated</p><p><b>Rare</b> (less than 0.1%): Hyperkalemia</p><p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Anemia, neutropenia, eosinophilia, thrombocytopenia</p><p><b>Very rare</b> (less than 0.01%): Pancytopenia, agranulocytosis, hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency, hemoglobin decreased, hematocrit decreased, platelets decreased, white cell count decreased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Rare</b> (less than 0.1%): Confusion, depression, sleep disturbances</p><p><b>Frequency not reported</b>: Nervousness, mood changes, anxiety<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Vision blurred<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very rare</b> (less than 0.01%): Hepatitis, liver enzymes elevated, serum bilirubin elevated<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Univasc (moexipril)." Schwarz Pharma, Mequon, WI. </p><h2>More about Univasc (moexipril)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: Angiotensin Converting Enzyme Inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Univasc &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Diabetic Kidney Disease</li>
<li>Heart Attack</li>
<li>Heart Failure</li>
<li>High Blood Pressure</li>
<li>Left Ventricular Dysfunction</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>